Promotion and Support for Physical Activity Maintenance Post Total Hip Arthroplasty (PANORAMA)

February 2, 2024 updated by: Theresa Bieler, Bispebjerg Hospital

Promotion and Support for Physical Activity Maintenance Post Total Hip Arthroplasty (PANORAMA). A Pragmatic, Randomized, Controlled, Trial.

Total hip arthroplasty (THA) is considered an efficacious procedure for relieving pain and disability in patients with hip osteoarthritis. However, 6-12 months post-surgery physical activity level is unchanged compared to pre-surgery and still considerably lower than that of healthy peers. Increasing physical activity after THA may enhance the outcome of the THA because a graded relationship between physical activity level and functional performance has been documented. Six-8 months after THA physical function is only recovered to about 80% of that of healthy peers and older adults still seem to be at increased risk of frailty. Furthermore, these patients continue to impose higher healthcare costs than an age- and sex-matched reference population which potentially could be related to the functional status that is not completely regained. Finally, patients with hip osteoarthritis can have extensive comorbidity thus increasing physical activity after THA could be a simple and relatively inexpensive method for improving general health, which in turn may decrease healthcare costs.

The reasons for the lack of increase in physical activity despite increased capability after THA are unknown but it may be related to the sedentary behavior adopted by the patients prior to surgery and uncertainty. A systematic review has illuminated that patient-reported barriers to engaging in physical activity after THA are largely related to limited or inadequate information or education culminating in uncertainty about 'doing the right thing' for both the individual's recovery and the longevity of the joint replacement.

Few studies have investigated the effects of specific interventions to increase physical activity after THA. Promising results have been shown from physical activity sensors in combination with e.g. goal setting. None of these studies have addressed the patient-reported barriers to physical activity regarding uncertainty and limited education.

This trial aims to investigate the effect of adding a pedometer-driven, behavior change intervention to usual rehabilitation care 3 months after THA to increase physical activity compared to usual rehabilitation care alone (control). Outcomes are taken 3 (baseline), 6 (after the intervention period) and 12 months after THA (follow-up).

Hypothesis: the behavior change intervention will increase the proportion that completes ≥8,000 steps per day 6-month post-surgery to 50% versus 30% in the control group.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

192

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Copenhagen, Denmark, 2400
        • Bispebjerg Hospital, Department of Physical & Occupational Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Home dwelling, independent and self-reliant adults
  • Patients who has received primary total hip arthroplasty because of hip osteoarthritis
  • Informed consent to participate

Exclusion Criteria:

  • Planned joint arthroplasty in the lower extremities within the next 6 months
  • Patients who are unable to read, understand and speak Danish
  • Complications in relation to total hip arthroplasty e.g. dislocation, fracture or infection
  • Any other condition that in the opinion of the investigator makes a potential participant unfit for participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavior change intervention
A 3-month behavior change intervention i.e. one initial, face-to-face, physical activity counselling and two telephone-assisted counselling.
It is a 3-month, multimodal, minimal contact, pedometer-driven, behavior change intervention to promote and support physical activity, that is initiated 3 months after THA. There is one initial, physiotherapist-led, face-to-face, physical activity counselling including 1) a brief motivational interviewing regarding physical activity, 2) patient education regarding physical activity after THA including recommendations and safety based on an "orthopedic surgeon guided" video and leaflet, 3) handling out pedometer and educational material i.e. a practice-oriented leaflet with advice on how to use a pedometer, a step-calendar and goal setting as well as strategies to incorporate physical activity into daily life. This initial counselling is followed by two, physiotherapist-led, telephone-assisted counselling after respectively three and seven weeks.
No Intervention: Control
No attention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of participants that complete ≥ 8,000 steps per day
Time Frame: 6 months after THA
The mean number of steps completed per day assessed by an accelerometer during a 7-day period.
6 months after THA

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of participants that complete ≥ 10,000 steps per day
Time Frame: 6 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
6 months after THA
Change from baseline in the 6-minute walk test
Time Frame: 6 months after THA
The 6-minute walk test is a performance-based test of physical function which covers the domain ability to walk over longer distances. It is also a proxy measure of endurance/aerobic capacity. This test measures the walking distance completed in 6 minutes on a 30-m flat course. The participant is instructed to walk as far as possible in 6 minutes. The 6-minute walk test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
6 months after THA
Change from baseline in the 30-s chair-stand test
Time Frame: 6 months after THA
The 30-s chair-stand test is a performance-based test of physical function which covers the domains: sitting and getting in/out of a seated position. It is also a proxy measure for assessing lower body muscle strength and power. This test measures number of chair stands completed in 30 seconds. The participant is instructed to complete as many chair stands as possible in 30 seconds with arms across the chest. The 30-s chair-stand test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
6 months after THA
Change from baseline in the stair-climb test
Time Frame: 6 months after THA
The stair-climb test is a performance-based test of physical function which covers the domains: mobility and climbing. It is also a proxy measure for assessing lower extremity muscle strength and power and balance. This test measures the time (best of two trials) to ascend and descend a flight of 10 steps. The participant is instructed to ascend and descend the flight of stairs as fast as possible. The stair-climb test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
6 months after THA
Change from baseline in self-reported physical function
Time Frame: 6 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the function in daily living (ADL) subscale. The last week is taken into consideration when answering the 17 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
6 months after THA
Change from baseline in hip pain
Time Frame: 6 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the pain subscale. The last week is taken into consideration when answering the 10 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
6 months after THA
Change from baseline in the patients' assessment of global perceived effect
Time Frame: 6 months after THA
The participants will be asked to compare their current global wellbeing with the pre-surgery state on a 200 mm visual analog scale with anchors being: -100 = "Much worse"; 0 = "No changes"; 100 = "Much better".
6 months after THA
The mean number of steps per day
Time Frame: 6 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
6 months after THA
The number of participants that complete ≥ 5,000 steps per day
Time Frame: 6 and 12 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
6 and 12 months after THA
Health-related quality of life
Time Frame: 6 and 12 months after THA
Assessed by the EuroQol 5-Dimension Questionnaire (EQ-5D-3L), a generic instrument with 5 questions that comprises 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with 3 levels: no problems, some problems, and extreme problems, where each dimension is assigned a score from 1 to 3, which can be converted into a single summary index value (based on the Danish EQ-5D Time Trade-Off (TTO) value set; 1 corresponds to the best possible health status, <0 represents the worst possible health status)
6 and 12 months after THA

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of participants that complete ≥ 8,000 steps per day
Time Frame: 12 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
12 months after THA
The number of participants that complete ≥ 10,000 steps per day
Time Frame: 12 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
12 months after THA
Change from baseline in the 6-minute walk test
Time Frame: 12 months after THA
The 6-minute walk test is a performance-based test of physical function which covers the domain ability to walk over longer distances. It is also a proxy measure of endurance/aerobic capacity. This test measures the walking distance completed in 6 minutes on a 30-m flat course. The participant is instructed to walk as far as possible in 6 minutes. The 6-minute walk test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
12 months after THA
Change from baseline in the 30-s chair-stand test
Time Frame: 12 months after THA
The 30-s chair-stand test is a performance-based test of physical function which covers the domains: sitting and getting in/out of a seated position. It is also a proxy measure for assessing lower body muscle strength and power. This test measures number of chair stands completed in 30 seconds. The participant is instructed to complete as many chair stands as possible in 30 seconds with arms across the chest. The 30-s chair-stand test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
12 months after THA
Change from baseline in the stair-climb test
Time Frame: 12 months after THA
The stair-climb test is a performance-based test of physical function which covers the domains: mobility and climbing. It is also a proxy measure for assessing lower extremity muscle strength and power and balance. This test measures the time (best of two trials) to ascend and descend a flight of 10 steps. The participant is instructed to ascend and descend the flight of stairs as fast as possible. The stair-climb test is included in a set of performance-based test recommended by the Osteoarthritis Research Society International that represents typical activities relevant to individuals following total joint arthroplasties.
12 months after THA
Change from baseline in self-reported physical function
Time Frame: 12 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the function in daily living (ADL) subscale. The last week is taken into consideration when answering the 17 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
12 months after THA
Change from baseline in hip pain
Time Frame: 12 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the pain subscale. The last week is taken into consideration when answering the 10 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
12 months after THA
Change from baseline in the patients' assessment of global perceived effect
Time Frame: 12 months after THA
The participants will be asked to compare their current global wellbeing with the pre-surgery state on a 200 mm visual analog scale with anchors being: -100 = "Much worse"; 0 = "No changes"; 100 = "Much better".
12 months after THA
Change from baseline in self-reported physical activity
Time Frame: 6 and 12 months after THA
Assessed by the Physical Activity Scale for the Elderly (PASE) that assesses the level of physical activity (occupational, household and leisure activities) over a one-week period. The score range is 0-400 or more (lowest to highest physical activity-level).
6 and 12 months after THA
Change from baseline in self-reported physical activity level
Time Frame: 6 and 12 months after THA
Assessed by a question "How physically active are you now?" from the Copenhagen City Heart Study (level 1-4; 1 = almost entirely sedentary, 2 = light physical activity (PA) for 2-4 h per week, 3 = light PA >4 h per week or more vigorous PA for 2-4 h per week, 4 = more vigorous PA >4 h per week or regular heavy exercise or competitive sports several times per week).
6 and 12 months after THA
Change from baseline in Health-related quality of life
Time Frame: 6 and 12 months after THA
Assessed by the EuroQol 5-Dimension Questionnaire (EQ-5D-3L), a generic instrument with 5 questions that comprises 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with 3 levels: no problems, some problems and extreme problems and a separate 20cm visual analog scale with anchors being: 0="worst imaginable health state"; 100="best imaginable health state".
6 and 12 months after THA
Change from baseline in self-efficacy for physical activity
Time Frame: 6 and 12 months after THA
Assessed by the exercise self-efficacy scale, which consists of 5 questions concerning the confidence of perceived ability to participate in exercise despite barriers as bad mood, bad weather, tiredness or lack of time (total score range, 5-25, worst to best).
6 and 12 months after THA
Change from baseline in task-specific self-efficacy
Time Frame: 6 and 12 months after THA
Assessed in conjunction with the stair-climbing test. After a practice trial, the participants are asked to rate their level of certainty that they can complete the stair-climbing task 2, 4, 6, 8, and 10 times without stopping (total score 0-100 (worst to best)).
6 and 12 months after THA
Change from baseline in outcome expectancy for physical activity
Time Frame: 6 and 12 months after THA
Assessed by the Outcome expectancy for exercise scale (OEE-2), an interviewer administered questionnaire with 13 questions regarding both positive and negative expectations associated with exercise. A positive outcome expectancy subscale, a negative outcome expectancy subscale and a total score can be calculated (more positive outcome expectations for exercise with higher score).
6 and 12 months after THA
Change from baseline in symptoms (other than pain)
Time Frame: 6 and 12 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the other symptoms subscale. The last week is taken into consideration when answering the 5 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
6 and 12 months after THA
Change from baseline in function in sport and recreation
Time Frame: 6 and 12 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the function in sport and recreation subscale. The last week is taken into consideration when answering the 4 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
6 and 12 months after THA
Change from baseline in hip-related quality of life
Time Frame: 6 and 12 months after THA
Assessed by the Hip disability and Osteoarthritis Outcome Score (HOOS), the hip-related quality of life subscale. The last week is taken into consideration when answering the 4 questions (5 Likert boxes) included in this subscale. A normalized score (0-100, worst to best) can be calculated.
6 and 12 months after THA
The mean number of steps per day
Time Frame: 12 months after THA
The mean number of steps completed per day assessed with an accelerometer during a 7-day period.
12 months after THA

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Theresa Bieler, PT, PhD, Bispebjerg and Frederiksberg Hospital, Dept. of Physical & Occupational Therapy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 31, 2020

Primary Completion (Actual)

July 3, 2023

Study Completion (Actual)

February 2, 2024

Study Registration Dates

First Submitted

July 7, 2020

First Submitted That Met QC Criteria

July 10, 2020

First Posted (Actual)

July 15, 2020

Study Record Updates

Last Update Posted (Estimated)

February 5, 2024

Last Update Submitted That Met QC Criteria

February 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • H-19050820

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Proposal for data use should be addressed to theresa.bieler@regionh.dk. Data access in Denmark is under very strict juristic data protection law. Any possible access or sharing demands a part application to: The Danish Data Protection Agency and The Ethics Committee of the Capital Region. Only if the applications are approved data will be considered available for sharing. The authors will not be able to support this process and a prolonged process must be expected.

IPD Sharing Time Frame

Statistical Analysis Plan (SAP) available from 19.12.23, Analytic Code unresolved

IPD Sharing Access Criteria

Please read plan description

IPD Sharing Supporting Information Type

  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty, Replacement, Hip

Clinical Trials on Behavior change intervention

3
Subscribe